Exane Derivatives’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $225 | Sell |
3
-43
| -93% | -$3.23K | ﹤0.01% | 661 |
|
|
2022
Q1 | $3.59K | Sell |
46
-12
| -21% | -$937 | ﹤0.01% | 712 |
|
|
2021
Q4 | $5.22K | Sell |
58
-392
| -87% | -$35.3K | ﹤0.01% | 608 |
|
|
2021
Q3 | $41.6K | Sell |
450
-95
| -17% | -$8.79K | 0.01% | 624 |
|
|
2021
Q2 | $37.8K | Hold |
545
| – | – | 0.01% | 651 |
|
|
2021
Q1 | $40.6K | Sell |
545
-91
| -14% | -$6.78K | 0.01% | 520 |
|
|
2020
Q4 | $108K | Hold |
636
| – | – | 0.03% | 379 |
|
|
2020
Q3 | $89.3K | Hold |
636
| – | – | 0.03% | 294 |
|
|
2020
Q2 | $102K | Hold |
636
| – | – | 0.03% | 274 |
|
|
2020
Q1 | $62.2K | Sell |
636
-1,387
| -69% | -$136K | 0.02% | 321 |
|
|
2019
Q4 | $263K | Hold |
2,023
| – | – | 0.05% | 214 |
|
|
2019
Q3 | $152K | Hold |
2,023
| – | – | 0.03% | 264 |
|
|
2019
Q2 | $307K | Hold |
2,023
| – | – | 0.05% | 205 |
|
|
2019
Q1 | $241K | Buy |
2,023
+285
| +16% | +$34K | 0.05% | 190 |
|
|
2018
Q4 | $190K | Buy |
1,738
+338
| +24% | +$36.9K | 0.03% | 227 |
|
|
2018
Q3 | $226K | Hold |
1,400
| – | – | 0.04% | 221 |
|
|
2018
Q2 | $185K | Buy |
+1,400
| New | +$185K | 0.03% | 250 |
|